Trials / Completed
CompletedNCT00293761
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 109 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Travoprost, Investigational | One drop in study eye once daily for 13 days |
| DRUG | Travoprost (TRAVATAN) | One drop in study eye once daily for 13 days |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2006-05-01
- Completion
- 2006-05-01
- First posted
- 2006-02-20
- Last updated
- 2016-11-18
Source: ClinicalTrials.gov record NCT00293761. Inclusion in this directory is not an endorsement.